Mark Novotny, O.D.
NPI 1063574176 · Optometrist · Gainesville, GA
Enrolled with Medicare as Practitioner - Optometry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Mark Novotny, O.D. is a Optometrist provider in Gainesville, GA (NPI 1063574176).
Provider details
- NPI number
- 1063574176
- Entity type
- Individual
- Primary specialty
- OptometristEye and Vision Services Providers
- Credential
- O.D.
- Sex
- Male
- Sole proprietor
- No
- License
- OPT001945 (GA)
Specialties & taxonomies
Eye and Vision Services Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
926 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Complete Exam of Visual System92014 | 385 | $120 |
| New Patient Complete Exam of Visual System92004 | 140 | $142 |
| Microfluid Analysis of Tears83861 | 115 | $22 |
| Imaging of Retina92134 | 115 | $39 |
| Established Patient Problem Focused Exam of Visual System92012 | 90 | $85 |
| New Patient Problem Focused Exam of Visual System92002 | 40 | $80 |
| Analysis of Substance Using Immunoassay Technique, Multiple Step Method |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 12 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Cyclosporinebrand: Restasis | 78 | 41 |
| Cyclosporine | 52 | 20 |
| Latanoprost | 50 | 19 |
| Tobramycin/Dexamethasonebrand: Tobramycin-Dexamethasone | 28 | 28 |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 26 | — |
| Cephalexin | 21 | 20 |
| Brimonidine Tartrate | 18 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$54 across 3 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-12-14
- Last updated
- 2007-07-08
Frequently asked questions
- What is Mark Novotny's NPI number?
- Mark Novotny's National Provider Identifier (NPI) is 1063574176, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Mark Novotny's specialty?
- Mark Novotny is listed in the NPPES registry with a primary specialty of Optometrist (Eye and Vision Services Providers).
- Where is Mark Novotny located?
- Mark Novotny's practice location on file with NPPES is 535 Jesse Jewell Pkwy Se, Gainesville, GA 30501-3772.
- What is Mark Novotny's phone number?
- The practice phone number listed in the NPPES registry for Mark Novotny is (770) 534-1711.
- Does Mark Novotny accept Medicare?
- Mark Novotny is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Mark Novotny's NPI active?
- Yes — Mark Novotny's NPI (1063574176) is active in the NPPES registry as of the last update on 2007-07-08.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.